LARS ligament in bone prosthesis replacement
Part of Cancer clinical trials.
This trial tests using a special ligament called LARS during surgery to replace a bone with a prosthetic (artificial) part. It aims to see if this approach helps people with certain types of bone cancer or tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can be any age, male or female.
- You must have a type of cancer that starts in the bone, confirmed by a biopsy at the study hospital.
- You must be scheduled to have surgery at the study hospital where a bone prosthesis is placed and a LARS ligament is used.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses custom 3D printed bone replacements to help save your limb during surgery for bone cancer. The goal is to see if these implants work well and improve your recovery.
This trial tests whether anti-osteoporosis medication can help prevent or treat bone damage caused by bone tumors. If you've had a bone tumor removed, this study may help protect your remaining bone strength.
This study checks how well LARS artificial ligaments work in the knee over the long term (9-12 years after surgery). It is not testing a new treatment; it is checking the results from surgery already done to understand safety and how well the ligament holds up.
This trial is testing whether removing a bone tumor and rebuilding the bone with a custom 3D-printed implant works well. It may help people with large bone tumors that can't be treated with standard prosthetics.
This trial tests whether using augmented reality (AR) – a technology that overlays digital images onto the real world – during liver tumor surgery is safe and practical. It aims to help surgeons remove tumors more precisely, which could lead to better outcomes for you.
This study looks at how well knee replacement and ligament surgery with specific devices work in real life. It helps doctors track patients' progress and results.
Hear when a new Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.